Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for OptimizeRx (OPRX) over the last 10 years, with Q3 2025 value amounting to $62000.0.

  • OptimizeRx's Other Non Operating Income rose 6315.79% to $62000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $177000.0, marking a year-over-year increase of 11211.43%. This contributed to the annual value of $152000.0 for FY2024, which is 6960.0% down from last year.
  • Per OptimizeRx's latest filing, its Other Non Operating Income stood at $62000.0 for Q3 2025, which was up 6315.79% from $37000.0 recorded in Q2 2025.
  • OptimizeRx's 5-year Other Non Operating Income high stood at $720419.0 for Q2 2023, and its period low was -$1.6 million during Q4 2023.
  • Moreover, its 5-year median value for Other Non Operating Income was $38500.0 (2024), whereas its average is $92182.0.
  • Over the last 5 years, OptimizeRx's Other Non Operating Income had its largest YoY gain of 2218230000.0% in 2023, and its largest YoY loss of 39230.19% in 2023.
  • OptimizeRx's Other Non Operating Income (Quarter) stood at $2382.0 in 2021, then surged by 22507.56% to $538512.0 in 2022, then tumbled by 392.3% to -$1.6 million in 2023, then soared by 102.48% to $39000.0 in 2024, then soared by 58.97% to $62000.0 in 2025.
  • Its last three reported values are $62000.0 in Q3 2025, $37000.0 for Q2 2025, and $39000.0 during Q1 2025.